Welcome to the Office of Cancer Survivorship Program, DCCPS
The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.
Stay up-to-date on everything from OCS @NCICancerSurv
Stay up-to-date on everything from DCCPS LinkedIn
Spotlight
Publication
Myths and Presumptions about Cancer Survivorship
In this Journal of Clinical Oncology publication, OCS Director Dr. Emily Tonorezos, Deputy Director Dr. Michelle Mollica, and coauthors discuss some commonly held beliefs related to cancer survivorship. Topics include shared care, provider preferences, and more.
Upcoming Presentation
OCS Director's Series presents Capturing Cancer Recurrence with Novel Data Linkages
December 2023 – Register now for this upcoming OCS Director’s Series webinar. On December 5, 2023, from 2-3 p.m. ET, Dr. Mia Hashibe will present Capturing Cancer Recurrence with Novel Data Linkages.
Upcoming Meetings
National Survivorship Standards Subject Matter Expert Consensus Meetings: An Initiative of the President’s Cancer Cabinet
December 2023 – On December 6, 2023, from 2-3 p.m. ET, NCI, Veterans Affairs, & other HHS agencies are holding the second of three virtual meetings to develop national standards for survivorship care, including indicators for health system policy, processes, and evaluation. Register now to view this second session. Registration for the third session, on December 12, 2023, is also available here.
Upcoming Meeting
Enhancing Capacity for Primary Care Research in Cancer Survivorship: A Workshop for Action
February 2024 – The NCI Office of Cancer Survivorship is conducting a virtual event, Enhancing Capacity for Primary Care Research in Cancer Survivorship: A Workshop for Action, on February 28, 2024, to discuss research needs for addressing the intersection between primary care and cancer survivorship. Learn more and register.
Funding Opportunities
About The Office of Cancer Survivorship
An individual is considered a cancer survivor from the time of diagnosis, through the balance of life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.
OCS works to promote a better understanding of unique needs of the growing population of cancer survivors, and to enhance our ability to address them.
Quick Links
Featured Graph and Statistic
Individuals Living with Metastatic Cancer
Researchers at the National Cancer Institute have estimated that 623,405 people in the United States were living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma as of 2018, and that number is expected to increase to 693,452 by the year 2025.
Cancer Survivor Statistics
It is estimated that there are 18.1 million cancer survivors in the United States. This represents approximately 5.4% of the population.